Literature DB >> 10993588

Variability in growth hormone stimulation tests.

S Fisker1, J O Jørgensen, J S Christiansen.   

Abstract

The diagnosis of growth hormone deficiency (GHD) in adulthood has become increasingly important because of the approved indication for growth hormone (GH) substitution therapy in such patients. While GH stimulation tests are superior to single measurements of other growth factors or spontaneous GH secretion in the diagnosis in adults, the reproducibility and specificity of GH stimulatory tests are often described to be low. This is also the case with the insulin tolerance test. Many external factors, such as fasting, physical activity, heat exposure and sleep, are known to influence GH secretion. The stimulatory or inhibitory effect of these factors on GH secretion might, therefore, influence the GH provocative test and contribute to the variability in response. Age and body composition are also known to influence GH secretion, and these factors must be considered when evaluating GH test responses. However, age-related cut-off levels for GHD have not been defined. Obesity is still a complicating factor in the diagnosis of GHD, even though some GH tests have been able to distinguish between obesity and true GHD. Based on these complicating factors, the parameters of GH stimulatory tests are recommended to be defined and standardized to optimize reproducibility and specificity. Furthermore, such tests should be performed only in patients with firm evidence of pituitary disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10993588     DOI: 10.1016/s1096-6374(98)80006-3

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  5 in total

1.  Growth hormone status in morbidly obese subjects and correlation with body composition.

Authors:  S Savastano; C Di Somma; A Belfiore; B Guida; F Orio; F Rota; M C Savanelli; T Cascella; A Mentone; L Angrisani; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

2.  Current practice in diagnosis and treatment of growth hormone deficiency in childhood: a survey from Turkey.

Authors:  Şükran Poyrazoğlu; Teoman Akçay; İlknur Arslanoğlu; Mehmet Emre Atabek; Zeynep Atay; Merih Berberoğlu; Abdullah Bereket; Aysun Bideci; İffet Bircan; Ece Böber; Şule Can; Yaşar Cesur; Şükran Darcan; Korcan Demir; Bumin Dündar; Betül Ersoy; İhsan Esen; Ayla Güven; Cengiz Kara; Mehmet Keskin; Selim Kurtoğlu; Nihal Memioğlu; Mehmet Nuri Özbek; Tolga Özgen; Erkan Sarı; Zeynep Şıklar; Enver Şimşek; Serap Turan; Ediz Yeşilkaya; Bilgin Yüksel; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-03

3.  Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency.

Authors:  Ju Young Yoon; Chong Kun Cheon; Jung Hyun Lee; Min Jung Kwak; Hyun-Ji Kim; Ye Jin Kim; Jeong Eun Lee; Woo Yeong Chung; Jeongyun Kim; Jae-Ho Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-01-17

Review 4.  GH Replacement in the Elderly: Is It Worth It?

Authors:  Silvia Ricci Bitti; Marta Franco; Manuela Albertelli; Federico Gatto; Lara Vera; Diego Ferone; Mara Boschetti
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-15       Impact factor: 5.555

5.  Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency.

Authors:  J M Garcia; R Swerdloff; C Wang; M Kyle; M Kipnes; B M K Biller; D Cook; K C J Yuen; V Bonert; A Dobs; M E Molitch; G R Merriam
Journal:  J Clin Endocrinol Metab       Date:  2013-04-04       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.